Abstract
It is well known that periconceptional folic acid supplementation decreases the risk of neural tube defects. The aim of this study was to evaluate the attitudes and practices of women with planned pregnancies regarding periconceptional folic acid intake and to identify factors associated with the use of this supplement. During 2 years of observation, we surveyed women with planned pregnancies who called our Teratology Information Service. A total of 500 women were surveyed: 217 (43.4 %) took folic acid before becoming pregnant, and 283 (56.6 %) did not take it. The women who took folic acid before becoming pregnant had a high education level and received preconception counselling. Our results suggest that less than half of Italian women took folic acid before they became pregnant although they were trying to conceive. Knowledge about the benefits of this vitamin is inadequate also among women who planned the pregnancy and the level of information received from their physicians.
Similar content being viewed by others
References
Lewis, C. J., Crane, N. T., Wilson, D. B., et al. (1999). Estimated folate intakes: Data updated to reflect food fortification, increased bioavailability, and dietary supplement use. American Journal of Clinical Nutrition, 70(2), 198–207.
Block, G., & Abrams, B. (1993). Vitamin and mineral status of women of childbearing potential. Annals of the New York Academy of Sciences, 678, 244–254.
Hibbard, E. D., & Smithells, R. W. (1965). Folic acid metabolism and human embryopathy. Lancet, 1, 1254–1256.
Lumley, J., Watson, L., Watson. M., & Bower, C. (2001). Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database of Systematic Reviews, (3), CD001056.
MRC Vitamin Study Research Group. (1991). Prevention of neural tube defects: Results of the medical research council vitamin study. Lancet, 338, 131–137.
Gong, R., Wang, Z. P., Gao, L. J., Lu, Q. B., Sun, X. H., & Zhao, Z. T. (2010). A case-control study of the effects of pregnancy planning on neural tube defects and its primary preventive measures. Birth Defects Research, Part A: Clinical and Molecular Teratology, 88(9), 737–742.
Busby, A., Armstrong, B., Dolk, H., et al. (2005). Preventing neural tube defects in Europe: A missed opportunity. Reproductive Toxicology, 20, 393–402.
Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recommendations and Reports, 41(RR-14), 1–7.
Lucock, M., & Lucock, Z. (2009). Folic acid fortification: A double-edged sword. Current Opinion in Clinical Nutrition and Metabolic Care, 12, 555–564.
Lawrence, M. A., Chai, W., Kara, R., et al. (2009). Examination of selected national policies towards mandatory folic acid fortification. Nutrition Reviews, 67(Suppl 1), S73–S78.
Arslan Özkan, I., & Mete, S. (2010). Pregnancy planning and antenatal health behaviour: Findings from one maternity unit in Turkey. Midwifery, 26(3), 338–347.
de Jong-van den Berg, L. T. W., Pharm, D., Hernandez-Diaz, S., Werler, M. M., et al. (2005). Trends and predictors of folic acid awareness and periconceptional use in pregnant women. American Journal of Obstetrics and Gynecology, 192, 121–128.
Available at http://www.entis-org.com. Accessed Nov 2011.
De Santis, M., Straface, G., Carducci, B., et al. (2004). Risk of drug-induced congenital defects. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 117(1), 10–19.
Chenga, D., Schwarzb, E. B., Douglasb, E., et al. (2009). Unintended pregnancy and associated maternal preconception, prenatal and postpartum behaviours. Contraception, 79, 194–198.
Neimanis, M., Paterson, J. M., & Bain, E. (1999). Preventing neural tube defects Survey of preconceptional use of folic acid. Canadian Family Physician, 45, 1717–2216.
Wilton, D. C., & Foureur, M. J. (2010). A survey of folic acid use in primigravid women. Women Birth, 23(2), 67–73.
de Walle, H. E. K., & de Jong-van den Berg, L. T. W. (2008). Ten years after the Dutch public health campaign on folic acid: The continuing challenge. European Journal of Clinical Pharmacology, 64, 539–543.
Abdulbari, B., Maadid, M. G. A., Al-Bast, D. A. E., et al. (2006). Maternal knowledge, attitude and practice on folic acid intake among Arabian Qatari women. Reproductive Toxicology, 21, 21–25.
Amitai, Y., Fisher, N., Meiraz, H., et al. (2008). Preconceptional folic acid utilization in Israel: Five years after the guidelines. Preventive Medicine, 46, 166–169.
Posner, S. F., Johnson, K., Parker, C., et al. (2006). The national summit on preconception care: A summary of concepts and recommendations. Maternal and Child Health Journal, 10, S197–S205.
Coll, O., Pisa, S., Palacio, M., et al. (2004). Awareness of the use of folic acid to prevent neural tube defects in a Mediterranean area. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 115(2), 173–177.
Elsinga, J., de Jong-Potjer, L. C., van der Pal-de Bruin, K. M., et al. (2008). The effect of PC on lifestyle and other behaviour before and during pregnancy. Women’s Health Issues, 18(6 Suppl.), S117–S125.
de Weerd, S., Polder, J. J., Cohen-Overbeek, T. E., et al. (2004). Preconception care: Preliminary estimates of costs and effects of smoking cessation and folic acid supplementation. Journal of Reproductive Medicine, 49(5), 338–344.
Pitkin, R. M. (2007). Folate and neural tube defects. American Journal of Clinical Nutrition, 85(1), 285S–288S.
Ying, Wu. D., Brat, G., Milla, G., et al. (2007). Knowledge and use of folic acid for prevention of birth defects amongst Honduran women. Reproductive Toxicology, 23, 600–606.
Sen, S., Manzoor, A., Deviasumathy, M., et al. (2001). Maternal knowledge, attitude and practice regarding folic acid intake during the periconceptional period. Public Health Nutr, 4, 909–912.
Abu-Hammad, T., Dreiher, J., Vardy, D. A., et al. (2008). Physicians’ knowledge and attitudes regarding periconceptional folic acid supplementation: A survey in Southern Israel. Medical Science Monitor, 14(5), CR262–CR267.
Morin, P., Demers, K., Giguère, C., et al. (2007). Multivitamin supplement for primary prevention of birth defects: Application of a preventive clinical practice. Canadian Family Physician, 53(12), 2142–2143.
De Wals, P., Tairou, F., Van Allen, M. I., et al. (2007). Reduction in neural-tube defects after folic acid fortification in Canada. New England Journal of Medicine, 357(2), 135–142.
Boulet, S. L., Yang, Q., Mai, C., et al. (2008). Trends in the post fortification prevalence of spina bifida and Anencephaly in the United States. Birth Defects Research (Part A), 82, 527–532.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
De Santis, M., Quattrocchi, T., Mappa, I. et al. Folic Acid Use in Planned Pregnancy: An Italian Survey. Matern Child Health J 17, 661–666 (2013). https://doi.org/10.1007/s10995-012-1047-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10995-012-1047-2